Novozymes Biopharma, Paras Biopharmaceuticals collaborate to generate Teriparatide
Teriparatide, a leading treatment for osteoporosis, a debilitating bone disease largely affecting women over 50 years of age
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.